Home » Topics » Conferences

Conferences
RSS

Korean researchers present novel 3-isoxazolylvinylcephalosporins

Oct. 3, 1997

R.W. Johnson identifies TCS inhibitor with potent antibacterial activity

Oct. 3, 1997

Microcide identifies cephalosporin with excellent Gram-positive activity

Oct. 3, 1997

Novel antibacterial agents that inhibit bacterial two-component systems

Oct. 3, 1997

Wakunaga prepares acidic fluoroquinolone

Oct. 3, 1997

Triazole antifungal from Uriach heading for clinic

Oct. 2, 1997

SynPhar selects class C beta-lactamase inhibitor as development candidate

Oct. 2, 1997

T-3811: a new des-F(6)-quinolone from Toyama presented at ICAAC

Oct. 2, 1997

Wakunaga develops new oral fluoroquinolones

Oct. 2, 1997

BioChem Therapeutic discovers new anti-HCMV agents

Oct. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...